We have shown that overall serum IFN-α activity is higher in SLE patients of non-European ancestry as compared to European ancestry, either directly or indirectly through an increased prevalence of anti-RBP antibodies (40, 41). The gene discussed is IFNA1; the disease is systemic lupus erythematosus.